Pictured: Jedd Wolchok & Richard Carvajal
In the Clinic
Memorial Sloan-Kettering Researchers Report on Major Advances in the Treatment of Metastatic Eye and Skin Melanoma
By Media Staff  |  Monday, June 3, 2013

Two Memorial Sloan-Kettering studies that hold promise for the treatment of advanced uveal (eye) melanoma and advanced skin melanoma are making headlines at the 49th Annual Meeting of the American Society of Clinical Oncology.

Cancer Care; Research; Clinical Research; Clinical Trials; Immunotherapy; Treatment; Melanoma; Skin Cancer
20 comments
Pictured: Melanocytes
Snapshot
Pigment-Producing Skin Cells Generated Using Stem Cell Technology
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, May 14, 2013

Memorial Sloan-Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.

Lab Research; Research; Stem Cells; Melanoma
1 comment
Pictured: Liang Deng
Profile
At Work: Physician-Scientist Liang Deng
By Jim Stallard, MA, Writer/Editor  |  Friday, April 26, 2013

Physician-scientist Liang Deng cares for patients with melanoma and other skin cancers, and also conducts innovative research on poxviruses.

Cancer Biology; Research; Immunology; Treatment; Melanoma
Add a Comment
Pictured: Jedd Wolchok
In the Clinic
Combining Two FDA-Approved Drugs May Be Harmful for Patients with Metastatic Melanoma
By Media Staff  |  Thursday, April 4, 2013

Early research led by investigators at Memorial Sloan-Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

Cancer Care; Research; Clinical Research; Clinical Trials; Immunotherapy; Treatment; Melanoma
Add a Comment
Pictured: Paul Chapman
Finding
New England Journal of Medicine Case Study Reveals New Information about Advanced Melanoma Treatment
By Memorial Sloan-Kettering  |  Friday, December 7, 2012

Memorial Sloan-Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.

Cancer Care; Research; Clinical Research; Treatment; Melanoma
3 comments
Pictured: Ping Chi
Q&A
At Work: Physician-Scientist Ping Chi
By Julie Grisham, MS, Science Writer/Editor  |  Friday, November 2, 2012

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

Cancer Care; Research; Cancer Genetics; Targeted Therapy; Melanoma; Soft Tissue Sarcoma
Add a Comment
Pictured: Patient James
Patient Story
James's Story about Melanoma
By Andrea Peirce, BA, Writer/Editor  |  Monday, October 15, 2012

James had advanced melanoma and dwindling treatment options when his doctors enrolled him in a clinical trial of an innovative immunotherapy developed at Memorial Sloan-Kettering.

Cancer Care; Survivorship; Melanoma
6 comments
Feature
Cancer Genomics: Improved Understanding of Molecular Changes in Tumors Produces More-Specialized Treatments
By Jim Stallard, MA and Julie Grisham, MS
Friday, September 21, 2012

With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.

Research; Acute Myelogenous Leukemia; Cancer Genetics; Colorectal Cancer; Leukemias; Lung Cancer; Melanoma; Pancreatic Cancer; Soft Tissue Sarcoma; Stomach (Gastric) Cancer
3 comments
Pictured: Jedd Wolchok
In the Clinic
Rare Medical Phenomenon: Melanoma Patient’s Tumors Disappear throughout the Body after Radiation of One Tumor
By Media Staff  |  Thursday, March 8, 2012

Findings from a multidisciplinary research team led by Memorial Sloan-Kettering medical oncologist and immunologist Jedd Wolchok could help shed light on the immune system’s role in fighting cancer.

Research; Clinical Research; Immunotherapy; Radiation Therapy; Immunology; Melanoma
5 comments
Pictured: Memorial Sloan-Kettering logo
In the News
Memorial Sloan-Kettering Made Major Contributions to Cancer Advances in 2011
By Julie Grisham, MS, Science Writer/Editor  |  Monday, February 6, 2012

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan-Kettering investigators.

Cancer Care; Research; Personalized Medicine; Targeted Therapy; Melanoma; Ovarian Cancer; Prostate Cancer
Add a Comment
Finding
Study Finds Most Children Don't Use Sunscreen Regularly
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, January 23, 2012

Research has shown that children who have experienced a sunburn at an early age are at almost double the risk for developing melanoma in adulthood. Now, a new study led by Memorial Sloan-Kettering epidemiologist Stephen Dusza finds that most children do not regularly use sunscreen.

Cancer Care; Health Outcomes & Statistics Research; Melanoma
Add a Comment
Honor
Memorial Sloan-Kettering Researchers Appointed to Stand Up To Cancer Melanoma “Dream Team”
By Media Staff  |  Wednesday, December 14, 2011

Five Memorial Sloan-Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma.

Research; Melanoma
Add a Comment
Pictured: David Solit
In the Lab
Researchers Discover Why New Melanoma Drug Stops Working
By Media Staff  |  Wednesday, November 23, 2011

Research led by investigators at Memorial Sloan-Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.

Research; Drug Discovery; Targeted Therapy; Melanoma

Featured Blog Posts

Large Genetic Study Could Improve Endometrial Cancer Diagnosis and Treatment
A Single Early PSA Test Found to Predict Long-Term Risk of Aggressive Prostate Cancer
Memorial Sloan-Kettering Experts Discuss Awake Surgery for Brain Tumors

Center News

Pictured: Center News, July 2013
Read Our Magazine »

Subscribe to Our E-newsletter

Get the latest information about cancer care.